fda glp 1 shortage semaglutide status january 2025 Federal judge upholds FDA's removal of Ozempic, Wegovy from drug list GLP-1 No Longer on FDA's – FDA Intensifies Crackdown on GLP-1

Weight loss is a major secondary benefit

The peptide (though technically considered a small molecule) is a potent fat-burning ergogen that inhibits NNMT (nicotinamide N-methyltransferase) a key player in cellular metabolism and energy homeostasis

For datasets with overlapping populations, we ensured that only the non-overlapping subset was included in the meta-analysis to avoid duplication bias

These medications may support fertility, mainly by improving metabolic health (like supporting weight loss)

Recent advances in SELEX technology and aptamer applications in biomedicine

Coenzyme Q10 (CoQ10), a mitochondrial cofactor with potent antioxidant properties, has also gained attention for its role in supporting energy production and reducing oxidative damage